Cargando…

Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease

BACKGROUND: Pain is a common nonmotor symptom in Parkinson's disease (PD). The pathophysiology of pain in PD is not well understood. Pain characteristics have rarely been studied in atypical parkinsonian disorders such as Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP). A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kass-Iliyya, Lewis, Kobylecki, Christopher, McDonald, Kathryn R, Gerhard, Alexander, Silverdale, Monty A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389053/ https://www.ncbi.nlm.nih.gov/pubmed/25874161 http://dx.doi.org/10.1002/brb3.320

Ejemplares similares

Small Fibre Neuropathy in Parkinson’s Disease: Comparison of Skin Biopsies from the More Affected and Less Affected Sides
por: Jeziorska, Maria, et al.
Publicado: (2019)

Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
por: Miki, Yasuo, et al.
Publicado: (2021)

Increased Intraepidermal Nerve Fiber Degeneration and Impaired Regeneration Relate to Symptoms and Deficits in Parkinson's Disease
por: Jeziorska, Maria, et al.
Publicado: (2019)

Corneal confocal microscopy detects small fibre neurodegeneration in Parkinson's disease using automated analysis
por: Lim, Sze Hway, et al.
Publicado: (2020)

Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
por: Guevara, C., et al.
Publicado: (2016)

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
por: Silverdale, Monty A., et al.
Publicado: (2018)

Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
por: Mitchell, Trina, et al.
Publicado: (2022)

Force Control Deficits in Individuals with Parkinson’s Disease, Multiple Systems Atrophy, and Progressive Supranuclear Palsy
por: Neely, Kristina A., et al.
Publicado: (2013)

Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy
por: Hu, Wen-Zheng, et al.
Publicado: (2023)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE
por: Payan, Christine A. M., et al.
Publicado: (2011)

Clinical Profile of Cognitive Decline in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy
por: Sulena,, et al.
Publicado: (2017)

Serum GDF-15 Levels in Patients with Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy
por: Miyaue, Noriyuki, et al.
Publicado: (2023)

Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
por: Müller, Sebastian Johannes, et al.
Publicado: (2023)

Orofacial pain in 1916 patients with early or moderate Parkinson disease
por: O'Neill, Francis, et al.
Publicado: (2021)

Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy
por: Brown, Jesse A., et al.
Publicado: (2017)

The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism Predominant
por: Madetko-Alster, Natalia, et al.
Publicado: (2022)

Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson’s Disease
por: Guevara, Carlos, et al.
Publicado: (2016)

Association between semantic dementia and progressive supranuclear palsy
por: Snowden, Julie S, et al.
Publicado: (2019)

Clinical Features and Disability Milestones in Multiple System Atrophy and Progressive Supranuclear Palsy
por: Lee, Sang-Wook, et al.
Publicado: (2012)

Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy
por: Worker, Amanda, et al.
Publicado: (2014)

Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
por: Rogozinski, Sophia, et al.
Publicado: (2022)

Speech acoustic indices for differential diagnosis between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy
por: Daoudi, Khalid, et al.
Publicado: (2022)

Fixel-Based Analysis of White Matter Degeneration in Patients With Progressive Supranuclear Palsy or Multiple System Atrophy, as Compared to Parkinson's Disease
por: Nguyen, Thanh-Thao, et al.
Publicado: (2021)

Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy
por: Jia, Peifei, et al.
Publicado: (2022)

Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature
por: Bougea, Anastasia
Publicado: (2023)

Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study
por: Kass-Iliyya, Lewis, et al.
Publicado: (2015)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

Impact of Quantitative Assessment of Parkinson’s Disease-Associated Symptoms Using Wearable Technology on Treatment Decisions
por: Carroll, Camille, et al.
Publicado: (2019)

Parkinson disease and progressive supranuclear palsy: protein expression in skin
por: Rodríguez‐Leyva, Ildefonso, et al.
Publicado: (2016)

Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy
por: Foley, Jennifer A., et al.
Publicado: (2018)

Diffusion Tensor Imaging of Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study
por: Worker, Amanda, et al.
Publicado: (2014)

Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy
por: Sakuramoto, Hirotaka, et al.
Publicado: (2019)

A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability
por: Rolland, Yan, et al.
Publicado: (2011)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Jabbari, Edwin, et al.
Publicado: (2020)

Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy
por: Talai, Aron S., et al.
Publicado: (2018)

Early Impairment of Chopsticks Skills in Parkinsonism Suggests Progressive Supranuclear Palsy
por: Kim, Young Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eamkev67mghcmsg2v336ee8tnk